SERVICES
EXPERTISES
Project Context
Solution
Outcome
Our client is a US-based tech company operating a B2B platform that enables pharmaceutical companies to manage and run clinical trials at scale.
Their platform serves clinical trial participants and Clinical Trial Managers (CTMs), incorporating AI-powered OCR technology to assess participant well-being through video submissions. While their platform excelled in backend capabilities, AI functionality, and participant-facing UX, the trial configuration process remained their operational Achilles' heel.
The bottleneck was costing time, money, and client satisfaction.
For pharmaceutical sponsors and CTMs, launching a new clinical trial should be straightforward. Instead, our client's customers faced a frustrating reality:
The outdated configuration tool lacked basic UX principles and offered no summaries or progress tracking. CTMs – highly skilled specialists who should be focusing on trial design and participant safety – were instead stuck chasing IT teams for status updates and corrections.
The stakes? Delayed trial launches mean delayed drug development timelines, which ultimately delays treatments reaching patients. For a B2B platform competing in the pharmaceutical tech space, this operational friction was a competitive liability.
Binariks dedicated an intensive discovery phase, assembling a specialized team that included a Clinical Trials Subject Matter Expert – allowing us to speak the language of pharmaceutical operations, not just software.
During discovery, we:
Team Structure
We matched team composition to each phase:
The Fullstack Tech Lead with integration expertise bridged our portal with the client's AWS-based platform, ensuring architectural alignment.
Execution Strategy
Rather than replacing the old tool, we built a self-service portal that empowered CTMs while maintaining IT oversight through a "master role." We captured test results in the client's Quality Management System format – critical for regulatory compliance.
Binariks delivered a standalone, self-service web portal that transformed clinical trial configuration from an IT-dependent bottleneck into an intuitive, automated workflow for clinical trial managers (CTMs).
Architecture Overview
The solution was designed to align with the client’s AWS ecosystem and existing DevOps practices, ensuring seamless integration and long-term maintainability:
A serverless architecture (AWS Lambda) was evaluated but replaced with a Kubernetes-based model to match the client’s infrastructure, CI/CD pipelines, and in-house expertise.
Architecture Decision
A serverless architecture (AWS Lambda) was evaluated but replaced with a Kubernetes-based model to match the client’s infrastructure. Forcing a Lambda-based approach would have created operational friction and slowed their ability to maintain the solution independently. The chosen architecture aligned with their existing CI/CD pipelines, deployment practices, and in-house team expertise.
Core Features and Capabilities
Extensive data mapping and validation during discovery ensured flawless backend integration and regulatory compliance.
Key Platform Capabilities
Data Integrity Foundation
Extensive data analysis and mapping ensured absolute alignment with the client's backend systems.
It was foundational work completed during discovery, including transformation and validation rules development that prevented the "we'll figure it out later" trap that derails many integration projects.
The configuration bottleneck is now a competitive advantage.
The numbers tell part of the story:
But the real impact goes deeper:
For CTMs and Pharmaceutical Sponsors:
For the Client's Business:
Compliance and Audit-Ready Governance Built In:
The portal maintains full compliance with FDA and the pharmaceutical industry regulations, including 21 CFR Part 11 (electronic records and signatures) and HIPAA (Health Insurance Portability and Accountability Act).
The architecture implements organization-level data isolation to prevent cross-contamination between pharmaceutical sponsors and provides comprehensive audit trails that capture every configuration change with user attribution and timestamps.
This regulatory-first design approach ensures pharmaceutical sponsors can confidently use the platform for clinical trials, knowing all compliance requirements are built into the foundation – not bolted on as an afterthought – and that audit-ready documentation and traceability are provided from day one.
In pharmaceutical technology, speed means getting treatments to patients faster.
By eliminating this operational bottleneck, the solution contributes to accelerating drug development timelines across multiple trials and pharmaceutical companies.